바로가기 메뉴
본문 바로가기
주메뉴 바로가기
푸터 바로가기

Information on the Test Items

Providing Information on the Test Items.

  • 홈
  • Diagnostic Laboratory Service
  • Information on the Test Items
  • Mycobacterium tuberculosis Drug Susceptibility Test

Mycobacterium tuberculosis Drug Susceptibility Test

Drug susceptibility testing for Mycobacterium tuberculosis is a test conducted to determine whether MTB isolated from tuberculosis patients are susceptible or resistant to first-line and second-line antituberculosis drugs.

Method

Absolute concentration method

  • <em>Mycobacterium tuberculosis</em> Drug Susceptibility Test 세포이미지
    Control
    Drug-free control medium
    Drug
    Antimicrobial Agent in Media
    Concentration
    Test concentration (mcg/mg)
    Para-nitrobenzoic acid (PNB)
    Medium for discrimination between Mycobacterium tuberculosis and non-tuberculous mycobacteria (NTM)
    Pyrazinamid
    Separate chemical testing using PZAse
  • <em>Mycobacterium tuberculosis</em> Drug Susceptibility Test cell image

Broth microdilution method using 7H9 broth

Test object :
For cases where rifampicin is resistant (R) based on previous drug susceptibility testing results (Additional testing will be conducted for eligible cases after result notification, with results provided two weeks later)
Reporting of
Test Results:

R (resistant): Tuberculosis bacterial growth

S (susceptible): Tuberculosis bacterial inhibition
Insurance Code D6013001
Classification Number 누-601나(1)(가)
Turnaround Time

4 weeks for positive solid and liquid culture specimens, 6 to 8 weeks for contaminated or low-growth cultures

Contact